Company / Cash per Share
Arcadia Biosciences, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.19
FY2025
5-year range
$0.19 / $37.22
FY2021-FY2025
Trend
-94.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 3 consecutive years, from $37.22 in FY2022 to $0.19 in FY2025.
Based on SEC 10-K filings.
0.19 in FY2025 with a 5-year CAGR of -34.9%.
Declined from $10.58 to $0.19 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -82.8%
- 5-Year CAGR
- -34.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 94.3% year-over-year.
- Peak cash per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.19 | -94.3% |
| FY2024 | $3.30 | -68.8% |
| FY2023 | $10.58 | -71.6% |
| FY2022 | $37.22 | +1645.4% |
| FY2021 | $2.13 | +31.3% |
| FY2020 | $1.62 | -7.9% |
| FY2019 | $1.76 | -58.8% |
| FY2018 | $4.28 | +372.5% |
| FY2017 | $0.90 | +66.8% |
| FY2016 | $0.54 | -93.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026